Register | Login

Praveen | Voted

Adding omega-3 fatty acids and other nutrients to standard antioxidant vitamins doesn't give older people any added protection against a leading cause of blindness, a new study finds. The study looked at age-related macular degeneration (AMD), which afflicts millions of older people in the United States, according to background information outlined by the researchers. The condition is "the leadin
A new trend among Japanese teens called oculolinctus, also known as “eyeball licking” or “worming,” has gone viral. The practice, in which teens show affection by licking their partner’s eyeballs, may have started with a scene in a music video released last year from the Japanese band Born, which features a dramatic slow-motion scene of oculolinctus, ABC News reported. But experts are concerned t
Cutting-edge wave front aberrometry can be used to help refractive surgeons predict the biomechanical stability of the cornea after LASIK surgery. "We all want to identify corneas that are weaker, even if they don't have any topographic abnormalities," Marcony Santhiago, MD, from the Federal University of Rio de Janeiro, Brazil, told Medscape Medical News. In their study, Dr. Santhiago and collea
Researchers at UC Berkeley have developed an easier and more effective method for inserting genes into eye cells that could greatly expand gene therapy to help restore sight to patients with blinding diseases ranging from inherited defects like retinitis pigmentosa to degenerative illnesses of old age, such as macular degeneration.
To see more details visit,
Two new studies add to the growing evidence that spending time outdoors may help prevent or minimize nearsightedness in children. A study conducted in Taiwan, which is the first to use an educational policy as a public vision health intervention, finds that when children are required to spend recess time outdoors, their risk of nearsightedness is reduced. A separate study in Danish children is th
For the first time, a systemic therapy has shown efficacy in a rare form of melanoma that affects the eye, uveal melanoma. New data showing activity with the investigational drug selumetinib, an MEK inhibitor under development by AstraZeneca, was hailed as a research "breakthrough" here at the 2013 Annual Meeting of the American Society of Clinical Oncology. Uveal melanoma is one of the most diff

First Drug to Help Melanoma of the Eye

Posted by Praveen (#2) 4020 days ago (Editorial)
AstraZeneca's experimental drug, selumetinib, is the first targeted medication to show a significant clinical benefit for patients with melanoma of the eye (metastatic uveal melanoma), researchers from the Memorial Sloan-Kettering Cancer Center explained at the 49th annual meeting of the American Society of Clinical Oncology (ASCO), in Chicago, Illinois.
To see more details visit,
The American Academy of Ophthalmology cautions consumers about the dangers of cosmetic eyelash extensions and the adhesives used to apply them to eyelids. Specific dangers of using these extensions include:
Infection of the cornea; Infection of the eyelid; Swelling of the eyelid; and Permanent or temporary loss of eyelashes. A 2013 article published in Consumer Reports titled, "Eyelash extension